(Q34659412)

3 August 2017

1 reference

title

Physical consequences of schizophrenia and its treatment: the metabolic syndrome (English)

1 reference

3 August 2017

0 references

1 reference

Martina C M Ryan

1

1 reference

PubMed ID

12034344

3 August 2017

Jogin H Thakore

series ordinal

2

1 reference

PubMed ID

12034344

3 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

3 August 2017

1 reference

3 August 2017

71

1 reference

3 August 2017

3

1 reference

3 August 2017

239-257

1 reference

Excess mortality in schizophrenia and affective disorders. Do suicides and accidental deaths solely account for this excess?

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Mortality in a cohort of patients with schizophrenia: a record linkage study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Mortality in DSM-IIIR schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Excess mortality of schizophrenia. A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Causes of the excess mortality of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

The mortality experience of individuals on the Salford Psychiatric Case Register. I. All-cause mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Mortality and causes of death in first admitted schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Excess mortality of mental disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

A record-linkage study of mortality and general hospital discharge in patients diagnosed as schizophrenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Causes of death in schizophrenia and manic-depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Mortality and causes of death in schizophrenic patients in Denmark

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Mortality in the long-stay population of Dutch mental hospitals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Mortality in schizophrenia. A ten-year follow-up based on the Stockholm County inpatient register

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

The unhealthy lifestyle of people with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Echocardiographic assessment of schizophrenics and manics: a reexamination of early necropsy findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

A twin study of mortality in schizophrenia and neurosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Physical activity, all-cause mortality, and longevity of college alumni

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Smoking and malignancy in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Mortality in psychiatric patients, with a specific focus on cancer mortality associated with schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Substance abuse and schizophrenia: editors' introduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Medical disorders in the schizophrenic patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Physical health of the long-term mentally ill in the community. Is there unmet need?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Cardiovascular and respiratory risk factors and symptoms among general practice patients with long-term mental illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

The distribution of body mass index among individuals with and without schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Fatness and fat patterns: associations with plasma lipids and blood pressures in adults, 18 to 57 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Evidence for a regional component of body fatness in the association with serum lipids in men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Relative contribution of obesity and body fat distribution to alterations in glucose insulin homeostasis: predictive values of selected indices in premenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Western nutrition and the insulin resistance syndrome: a link to breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

The metabolic syndrome X.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Mortality and medical comorbidity among psychiatric patients: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Diabetes mellitus in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Medical comorbidity in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Family history of type 2 diabetes in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Resistance to insulin in mentally disturbed soldiers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Platelet aggregation and dense granule secretion in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Prostaglandin E1 suppression of platelet aggregation response in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Platelet aggregation response in schizophrenia and prostaglandin E1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Sinus tachycardia and abnormal cardiac rate variation in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Altered balance in the autonomic nervous system in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Autonomic nervous system activity in acute schizophrenia: II. relationships to short-term prognosis and clinical state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Role of the sympathetic adrenal system in the pathogenesis of the insulin resistance syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Relation of obesity and diet to sympathetic nervous system activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Blood pressure in relation to obesity, insulin and the hypothalamic-pituitary-adrenal axis in Swedish men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Circadian and Sleep-Related Endocrine Rhythms in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Raised plasma cortisol concentrations a feature of drug-free psychotics and not specific for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

The effects of metabolic stress on plasma progesterone in healthy volunteers and schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Drugs and the DST: need for a reappraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Abnormal dexamethasone suppression test results in chronic schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Dexamethasone suppression test in positive and negative schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Hypothalamic-pituitary-adrenal axis function in chronic schizophrenia: association with clinical features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Hypothalamic-pituitary-adrenal axis hyperactivity and psychosis: recovery during an 8-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

The corticotropin-releasing hormone stimulation test in chronic schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Selective impairments in the stress response in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

The interactions between hypothalamic-pituitary-adrenal axis activity, testosterone, insulin-like growth factor I and abdominal obesity with metabolism and blood pressure in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

The effects of cortisol on insulin sensitivity in muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Life-Threatening Ventricular Arrhythmia (Torsades de Pointes) after Haloperidol Overdose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Drug-induced torsade de pointes. Incidence, management and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Long-term treatment with antipsychotic drugs in conventional doses prolonged QTc dispersion, but did not increase ventricular tachyarrhythmias in patients with schizophrenia in the absence of cardiac disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Electrocardiographic changes induced by phenothiazine drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

QT interval prolongation in type 2 (non-insulin-dependent) diabetic patients with cardiac autonomic neuropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Induction of obesity by psychotropic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Cigarette smoking, weight gain, and coronary mortality: results from the Chicago Western Electric Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Early body size and subsequent weight gain as predictors of breast cancer incidence (Iowa, United States).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Weight change and risk of heart attack in middle-aged British men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Relationship between weight change in young adulthood and the risk of NIDDM. The Sotetsu Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Atypical antipsychotics and weight gain--a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

New onset diabetes and atypical antipsychotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

The effect of clozapine on glucose metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Serum triglyceride levels in patients treated with clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

The impact of clozapine treatment on serum lipids in chronic schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Olanzapine increases weight and serum triglyceride levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901646-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(02)01646-6

1 reference

3 August 2017

1 reference

PubMed ID

12034344